These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31900514)

  • 21. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
    Boonya-ussadorn T; Choi WH; Hyun J; Kim SH; Chung SK; Yoo IeR
    J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
    Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing the clinical diagnosis of the acute and subacute phases of autoimmune encephalitis and predicting the risk factors: the potential advantages of 18F-FDG PET/CT.
    Liu L; Lyu Z; Li H; Bai L; Wan Y; Li P
    BMC Med Imaging; 2023 Nov; 23(1):193. PubMed ID: 37986052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections.
    Ankrah AO; Span LFR; Klein HC; de Jong PA; Dierckx RAJO; Kwee TC; Sathekge MM; Glaudemans AWJM
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):174-183. PubMed ID: 30343434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results.
    Schmitz A; Risse JH; Grünwald F; Gassel F; Biersack HJ; Schmitt O
    Eur Spine J; 2001 Dec; 10(6):534-9. PubMed ID: 11806396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
    Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
    Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
    Pennings JP; de Haas RJ; Murshid KJA; de Jong KP; Dierckx RAJO; Kwee TC
    Eur J Surg Oncol; 2019 Apr; 45(4):606-612. PubMed ID: 30594404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In the evaluation of patients with skull base osteomyelitis, does 18F-FDG PET CT have a role?
    Kulkarni SC; Padma S; Shanmuga Sundaram P
    Nucl Med Commun; 2020 Jun; 41(6):550-559. PubMed ID: 32282638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of 18F-FDG PET/CT uptake with severity of MRI findings and epidural steroid injection sites in patients with symptomatic degenerative disease of the lumbar spine: a retrospective study.
    Lam M; J Burke C; R Walter W
    Diagn Interv Radiol; 2021 Jul; 27(4):580-586. PubMed ID: 34313246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in penile cancer.
    Zhang S; Li W; Liang F
    Oncotarget; 2016 Jul; 7(30):48600-48606. PubMed ID: 27203206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of MRI, [
    Paez D; Sathekge MM; Douis H; Giammarile F; Fatima S; Dhal A; Puri SK; Erba PA; Lazzeri E; Ferrando R; Filho PA; Magboo VP; Morozova O; Núñez R; Pellet O; Mariani G
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1864-1875. PubMed ID: 33210240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET in the clinical work-up of patients with spondylodiscitis: a new tool for the clinician?
    Skanjeti A; Penna D; Douroukas A; Cistaro A; Arena V; Leo G; Longo G; Traverso A; Belloro S; Pelosi E
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):569-76. PubMed ID: 23358410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
    Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V
    Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?
    Schaarschmidt BM; Gomez B; Buchbender C; Grueneisen J; Nensa F; Sawicki LM; Ruhlmann V; Wetter A; Antoch G; Heusch P
    Diagn Interv Radiol; 2017; 23(2):127-132. PubMed ID: 28089955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [
    Azad GK; Taylor BP; Green A; Sandri I; Swampillai A; Harries M; Kristeleit H; Mansi J; Goh V; Cook GJR
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):821-830. PubMed ID: 30506455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining the Diagnostic Value of 18F-Fluorodeoxyglucose Positron Emission/Computed Tomography in Detecting Prosthetic Aortic Graft Infection.
    Mitra A; Pencharz D; Davis M; Wagner T
    Ann Vasc Surg; 2018 Nov; 53():78-85. PubMed ID: 30012456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG PET/CT in primary brain lymphoma.
    Albano D; Bosio G; Bertoli M; Giubbini R; Bertagna F
    J Neurooncol; 2018 Feb; 136(3):577-583. PubMed ID: 29147860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis.
    Nanni C; Boriani L; Salvadori C; Zamparini E; Rorato G; Ambrosini V; Gasbarrini A; Tumietto F; Cristini F; Scudeller L; Boriani S; Viale P; Fanti S
    Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1538-44. PubMed ID: 22820649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.